Qualitative Study About Psychedelics Using in Psychiatric Disorders (PSYCHEQUALI)
This observational, case-only study (n=25) will investigate the self-administered therapeutic use of psychedelics in people with psychiatric disorders.
Detailed Description
This prospective, observational case-only study will interview 25 adult patients in France who have used psychedelic substances to alleviate psychiatric symptoms in the context of a diagnosed psychiatric disorder.
Data are collected via semi-structured interviews and analysed using thematic analysis to describe patterns of use, perceived benefits and harms, and contextual factors.
Sampling is non-probability; participants must be affiliated to social security and provide oral non-opposition. Exclusions include inability to understand French and legal guardianship.
Study Arms & Interventions
Patients using psychedelics
experimentalAdult patients self-administering psychedelic substances in psychiatric disorders; case-only arm assessed by interview.
Interventions
- Compoundvia Other• single session
Semi-structured diagnostic interview to describe experiences of using psychedelic substances for therapeutic purposes.
Participants
Inclusion Criteria
- Inclusion Criteria:
- Patients diagnosed with a psychiatric disorder by a psychiatrist or general practitioner
- Patients used psychedelic or related substances in order to treat psychiatric symptoms
- Patients have given their oral non-opposition
- Patients affiliated to a social security scheme
Exclusion Criteria
- Exclusion Criteria:
- Patients who don't speak or understand French
- Patients under protection, guardianship or curators
Study Details
- StatusUnknown status
- PhasePhase NA
- Typeobservational
- DesignNon-randomized
- Target Enrollment25 participants
- TimelineStart: 2023-11-30End: 2025-03-10
- Topic